Perspective
A comparison of the clinical and microbiological effects of syndromic pneumonia molecular testing in intensive care units
Author(s): David Harrison*
Pneumonia is one of the most prevalent diagnoses in the intensive care unit, with high fatality rates and substantial healthcare expenditures. Antimicrobial therapy may be targeted using microbiological diagnostics, which has been shown to enhance patient outcomes. Due to the time necessary to produce results, standard sputum culture has limitations. To quickly detect infections, Bio Fire offers a syndromic panel of multiplex PCR. This research looked at ICU admission, antibiotic treatment, and consequences for patients. The study looked at the admission information of radiologically confirmed pneumonia patients admitted to Hull Hospitals' ICUs between August 1 and December 31, 2018, before and after Bio Fire testing was implemented. In the 2018 and 2019 study periods, 139 and 120 patients, respectively, had radiologically diagnosed pneumonia and sputum samples sent to the laborat.. Read More»
DOI:
10.37532/ puljcmid.2022.5(3).20-21
+447723598358
